Medivolve Inc. (MEDVF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 10, 2026
Medivolve Market Cap
Medivolve has a market cap or net worth of $2.7 thousand as of October 14, 2026. It is the 52,191st most valuable company in the world and the 8,219th biggest in the United States. Its market cap has increased by 9,907.41% in one year.
Market Cap
2.70K
Enterprise Value
n/a
Revenue
666.14K
Global Rank
Country Rank
#8,219 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since August 4, 2009, Medivolve's market cap has decreased from 22.21M to 2.70K, a decrease of -99.99%. That is a compound annual growth rate of -41.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 2.70K | -98.33% |
| Dec 31, 2024 | 162.12K | -44.95% |
| Dec 29, 2023 | 294.51K | -88.49% |
| Dec 30, 2022 | 2.56M | -89.25% |
| Dec 31, 2021 | 23.79M | -50.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProPhase Labs | 160.63K |
| Medical Imaging | 63.82K |
| T2 Biosystems | 22.44K |
| CardioGenics Holdings | 14.29K |
| RushNet | 8.77K |
| Todos Medical | 3.32K |
| Arrayit | 1.13K |
| Rosetta Genomics | 593.00 |